Astrazeneca Cash Flow Statement (2009-2026) | AZN

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Cash Flow Statement	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Mar2026
Operating Activities
Net Income (Quarter)	-0.43B	-0.02B	0.11B	0.15B	1.47B	-0.72B	-0.94B	0.08B	0.27B	0.27B	-0.88B	0.62B	0.47B	-0.83B	0.17B	-0.62B	-0.43B	0.67B	-0.15B	0.83B
Share-based Compensation (Quarter)
Cash from Discontinued Operations (Quarter)		1.72B	1.42B	3.23B	1.25B		7.41B	3.13B	1.72B		7.96B	2.49B	3.08B	3.38B	2.91B	3.71B	3.39B	5.13B	2.34B	3.36B
Gains from Sales and Divestitures (Quarter)	-0.35B	-0.37B	-0.51B	-0.01B	-0.08B		-0.10B	-0.25B	-0.25B		-0.25B		-0.02B	-0.03B	-0.06B	-0.07B	-0.09B	-0.12B	-0.17B	-0.03B
Gains from Investment Securities (Quarter)	0.64B	-0.33B	-0.26B	-0.23B	-0.73B	-0.68B	1.80B	-0.23B	-0.84B			-0.43B	-0.91B	-0.64B	1.97B	-0.36B	-1.19B	-0.64B	2.18B	-0.53B
Cash from Restructuring (Quarter)
Non-cash Items (Quarter)	4.02B	6.26B	8.43B	3.65B	5.87B			3.62B	6.39B			3.26B	7.49B	12.01B	15.92B	4.50B	9.27B	15.49B	18.74B	4.33B
Change in Working Capital (Quarter)		-13.13B	3.98B	5.35B	-2.96B			5.83B	-0.36B			7.69B	-1.01B	-2.24B	0.99B	5.21B	1.82B	1.05B	-2.38B	7.51B
Change in Account Payables (Quarter)
Change in Taxes (Quarter)			-1.20B	-0.23B			-1.33B	-0.23B			-2.37B	-0.43B			-2.75B	-0.36B			-0.65B	-0.53B
Cash from Operations (Quarter)
Depreciation, Depletion & Amortization
Depreciation & Amortization (CF) (Quarter)		2.79B	2.19B	1.31B	1.36B		4.00B	1.50B	1.28B		4.06B	1.25B	1.28B	1.82B	2.34B	1.28B	1.39B	1.55B	1.51B	1.37B
Investing Activities
Capital Expenditures (Quarter)		-0.26B	0.95B	-0.22B	-0.25B			-0.25B	-0.27B			-0.42B	-0.38B	-0.42B	3.14B	-0.43B	-0.66B	-0.69B	4.58B	-0.55B
Sales of Property, Plant and Equipment (Quarter)		-0.18B	0.20B	0.03B	0.00B			0.01B	-0.04B			-0.04B	-0.03B	-0.03B	0.17B	0.00B	-0.19B	-0.03B	0.23B	-0.01B
Change in Intangibles (Quarter)		-0.40B	-0.40B	-0.14B	-0.29B			-1.22B	-0.21B			-1.19B	-0.29B	-0.94B	-0.25B	-0.54B	-1.26B	-1.04B	-0.25B	-0.99B
Acquisitions (Quarter)		-24.83B		5.76B	-0.94B			-0.19B				-0.73B	-2.04B			5.23B	1.83B	-7.12B	-0.01B	7.56B
Change in Acquisitions & Divestments (Quarter)		-0.01B	-0.02B	0.02B	-0.01B			0.01B	0.08B			-0.06B	0.10B	0.03B	-0.04B	0.00B	0.11B	0.01B	0.01B	-0.09B
Cash from Investing Activities (Quarter)		-10.46B	-0.91B	-0.17B	-0.80B			-1.25B	-0.52B			-2.41B	-2.87B	-1.51B	-1.18B	-1.25B	-2.11B	-2.00B	-1.45B	-1.79B
Financing Activities
Other financing activities (Quarter)		-8.62B	-6.85B	5.35B	-0.87B			5.83B	-0.36B			7.69B	-1.01B	-2.24B	0.99B	5.21B	1.82B	1.05B	-2.38B	7.51B
Cash from Financing Activities (Quarter)		-10.16B	-5.60B	-3.74B	-1.29B		-6.46B	-2.03B	-1.52B		-6.57B	2.03B	-1.22B	-4.13B	-4.00B	-2.71B	0.52B	-2.07B	-3.28B	0.27B
Debt Issuance and Repayment
Net Debt Issuances and Repayments (Quarter)				3.06B	0.45B		4.70B	1.89B	1.20B		4.98B	0.07B	0.21B	1.87B	1.73B	2.46B	1.28B	3.13B	0.90B	1.57B
Dividend Payments
Dividends Paid - Common (Quarter)		-1.39B	7.71B	-2.97B				-3.05B	-0.02B			-3.03B	-0.02B	-1.58B	9.26B	-3.35B	-0.01B	-1.61B	9.94B	-3.29B
Additional items
Exchange Rate Effect (Quarter)		-0.02B	0.01B	-0.01B	-0.03B			-0.01B	-0.04B			-0.05B	-0.01B	0.02B	-0.06B	0.03B	0.03B	-0.01B	0.00B	-0.02B
Change in Cash (Quarter)		-0.16B	-8.99B	-0.68B	-0.85B			-0.14B	6.13B			5.64B			-5.75B	5.43B			-5.21B	5.70B
Free Cash Flow (Quarter)		0.26B	-0.95B	0.22B	0.25B			0.25B	0.27B			0.42B	0.38B	0.42B	-3.14B	0.43B	0.66B	0.69B	-4.58B	0.55B
Net Cash Flow (Quarter)		-20.62B	-6.51B	-3.91B	-2.10B		-6.46B	-3.28B	-2.04B		-6.57B	-0.39B	-4.09B	-5.64B	-5.18B	-3.96B	-1.59B	-4.07B	-4.73B	-1.52B

Research Tools

Developers

Astrazeneca Cash Flow Statement (2009-2026) | AZN

Research Tools

Developers

Astrazeneca Cash Flow Statement (2009-2026) | AZN

Create an account

Sign In

Reset Password